GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.300
-0.070 (-5.11%)
May 13, 2026, 4:00 PM EDT - Market closed
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $3.76 million as of May 13, 2026. Its market cap has decreased by -72.81% in one year.
Market Cap
3.76M
Enterprise Value
1.52M
1-Year Change
-72.81%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $3.76M, an increase of 1,467.59%. That is a compound annual growth rate of 51.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 3.76M | -48.80% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulmatrix | 4.57M |
| 60 Degrees Pharmaceuticals | 3.96M |
| Alzamend Neuro | 3.88M |
| Indaptus Therapeutics | 3.88M |
| Revelation Biosciences | 3.87M |
| Galmed Pharmaceuticals | 3.85M |
| VivoSim Labs | 3.79M |
| Matinas BioPharma Holdings | 3.78M |